Showing results (241-250 of 253) with videos related to
Sort By:
Pageof 26
Journal of the American Pharmacists Association : Japha|November 6, 2022
A data-driven quality-score system for rating drug products and its implications for the health care industryArash Dabestani, Sara Grossman, Joseph P Nathan, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|September 4, 2019
Current role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statementH Peach, R Board, M Cook, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre studyG A McArthur, M Maio, A Arance, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)T Powles, J Brown, J Larkin, et al.Journal of the American Medical Directors Association|June 15, 2021
Antibody Responses After mRNA-Based COVID-19 Vaccination in Residential Older Adults: Implications for ReopeningDavid A Nace, Kevin E Kip, John W Mellors, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 4, 2023
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysisJ M Piulats, C Watkins, M Costa-García, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines CommitteeO Michielin, A van Akkooi, P Lorigan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines CommitteeU Keilholz, P A Ascierto, R Dummer, et al.European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.Pageof 26